|
|
| (46 intermediate revisions by 2 users not shown) |
| Line 5: |
Line 5: |
| | <style> | | <style> |
| | #section_title { | | #section_title { |
| − | color: #ff0000; | + | color: #ff3333; |
| | background-color: #fff5efff; | | background-color: #fff5efff; |
| | text-align: center; | | text-align: center; |
| Line 21: |
Line 21: |
| | | | |
| | .heading { | | .heading { |
| − | color: #ff0000 !important; | + | color: #ff3333 !important; |
| | } | | } |
| | | | |
| Line 36: |
Line 36: |
| | } | | } |
| | | | |
| − | .logo-align{ | + | .logo-align { |
| | text-align: center; | | text-align: center; |
| | + | } |
| | + | |
| | + | .references{ |
| | + | font-size: 12px !important; |
| | } | | } |
| | </style> | | </style> |
| Line 82: |
Line 86: |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| | <div class="text"> | | <div class="text"> |
| − | <p>Presented by Team Paris Bettencourt 2020</p> | + | <p>By Team Paris Bettencourt 2020</p> |
| | <br /> | | <br /> |
| | <p><b>Amandine Maire<sup>1</sup>, Anu Susan Kurian<sup>1</sup>, Chetan Kumar | | <p><b>Amandine Maire<sup>1</sup>, Anu Susan Kurian<sup>1</sup>, Chetan Kumar |
| | Velumurugan<sup>1</sup>, Nicolas Levrier<sup>1</sup>, Nikola Zarevski<sup>1</sup>, | | Velumurugan<sup>1</sup>, Nicolas Levrier<sup>1</sup>, Nikola Zarevski<sup>1</sup>, |
| − | Valerie March<sup>1</sup>, Xavier Olessa-Daragon<sup>1</sup>, Ariel | + | Valerie March<sup>1</sup>, Xavier Olessa-Daragon<sup>1</sup></b>, Ariel |
| − | Lindner<sup>2</sup>, Jake Wintermute<sup>2</sup>, Radoslaw Ejsmont<sup>2</sup>,
| + | Lindner<sup>2</sup>, Jake Wintermute<sup>2</sup>, Radoslaw Ejsmont<sup>2</sup>, |
| − | Alexis Casas<sup>2</sup>, Darshak Bhatt<sup>2</sup></b></p>
| + | Alexis Casas<sup>2</sup>, Darshak Bhatt<sup>2</sup></p> |
| | <br /> | | <br /> |
| | <p><b><sup>1</sup>Student Team Member</b>, <sup>2</sup>Team Mentor</p> | | <p><b><sup>1</sup>Student Team Member</b>, <sup>2</sup>Team Mentor</p> |
| | <br /> | | <br /> |
| − | <b>Abstract</b> | + | <b class="heading">Abstract</b> |
| − | <p></p> | + | <p>SynDerma envisions therapeutics being administered by engineered microbes |
| | + | integrated into the skin microbiome. First, to understand the influence on the skin |
| | + | microbiome of individual habits such as hygiene, social interaction and exercise, which |
| | + | are all affected by this current unprecedented context of COVID-19 pandemic, we |
| | + | developed a community science project called Quaranskin. In Quaranskin we developed an |
| | + | at-home sampling kit, protocol and survey, in which participants swab four body sites |
| | + | for metagenomic analysis. Further implementation of this study will enable us to |
| | + | correlate the diversity and composition of those microbiome-data, to behaviours noted in |
| | + | the surveys, to uncover any trends. In parallel, we chose the skin commensal microbe |
| | + | <i>Staphylococcus epidermidis</i> to be a chassis for our future vision of microbial |
| | + | therapeutics enabled by synthetic biology. In projects EpiFlex, EpiGlow, and EpiGrow, we |
| | + | built a MoClo kit, expressed fluorescent proteins as a proof of concept, and optimised |
| | + | growth conditions, respectively. |
| | + | </p> |
| | </div> | | </div> |
| | </div> | | </div> |
| Line 117: |
Line 134: |
| | <p><b class="heading">1. Sample and Sequence the Human Skin Microbiome</b></p> | | <p><b class="heading">1. Sample and Sequence the Human Skin Microbiome</b></p> |
| | <p>Our first objective, pursued as part of the Quaranskin project, is to study the impact of | | <p>Our first objective, pursued as part of the Quaranskin project, is to study the impact of |
| − | environmental and behavioral factors on the skin microbiome and to provide a new | + | environmental and behavioral factors on the skin microbiome, and to provide a new |
| | database to study its composition in the context of reduced social and environmental | | database to study its composition in the context of reduced social and environmental |
| | interactions. | | interactions. |
| Line 125: |
Line 142: |
| | <p><b class="heading">2. Design tools to engineer the bacterium <i>S. epidermidis</i></b> | | <p><b class="heading">2. Design tools to engineer the bacterium <i>S. epidermidis</i></b> |
| | </p> | | </p> |
| − | <p>Our second objective is to make S. epidermidis an efficient synthetic biology chassis | + | <p>Our second objective is to make <i>S. epidermidis</i> an efficient synthetic biology chassis |
| | that can be used to monitor the population dynamics of the skin microbiome. This in | | that can be used to monitor the population dynamics of the skin microbiome. This in |
| | order to maintain its equilibrium and to avoid pathologies induced by dysbiosis. | | order to maintain its equilibrium and to avoid pathologies induced by dysbiosis. |
| Line 162: |
Line 179: |
| | <br /> | | <br /> |
| | <br /> | | <br /> |
| − | <p class="padding-left">As this situation was unprecedented, we were wondering if the | + | <p class="padding-left">Public health was one of our primary concerns during the lockdown. We were intrigued by the question of the impact that the lockdown could have on our health. This led us to examine the skin microbiome. |
| − | lockdown could have an
| + | |
| − | impact on human health and more specifically on the composition of our skin
| + | |
| − | microbiome.
| + | |
| | </p> | | </p> |
| | </div> | | </div> |
| Line 173: |
Line 189: |
| | | | |
| | <div class="subsection two_thirds"> | | <div class="subsection two_thirds"> |
| − | <p class="padding-right">We met some dermatologists as Stéphanie Leclerc-Mercier. She | + | <p class="padding-right">Through our experience and the advice gathered from health experts, we decided to study the human skin microbiome. The impact of sanitary measures on the skin microbiome, in particular frequent washing of hands and other surfaces of the body, which has proven to be crucial for populations with eczema symptoms, legitimated our approach. This discussion drew our interest for dysbiosis induced pathologies and possible treatments involving synthetic biology. |
| − | pointed out the fact
| + | |
| − | that the new sanitary measures and hygiene habits imposed by the pandemic were a
| + | |
| − | real issue for people with eczema symptoms since they cannot wash their hands as
| + | |
| − | often as healthy people. This discussion drew our interest for dysbiosis induced
| + | |
| − | pathologies and ways to treat them using synthetic biology.
| + | |
| | </p> | | </p> |
| | </div> | | </div> |
| Line 196: |
Line 208: |
| | <br /> | | <br /> |
| | <br /> | | <br /> |
| − | <p class="padding-left">Our team personal values led us to create a project who enters | + | <p class="padding-left">While lockdown posed a threat to social interactions, we wanted to connect people through science by putting Open and Citizen Science at the core of our 2020 iGEM project. |
| − | in
| + | |
| − | the framework of
| + | |
| − | Open and Citizen Science. Especially during the lockdown which forced us to be
| + | |
| − | physically isolated of each other, we wanted to find a way to connect people through
| + | |
| − | science.
| + | |
| | </p> | | </p> |
| | </div> | | </div> |
| Line 223: |
Line 231: |
| | <div class="text"> | | <div class="text"> |
| | <p><b class="heading">1. Study the Skin Microbiome</b></p> | | <p><b class="heading">1. Study the Skin Microbiome</b></p> |
| − | <p>Human skin microbiome sampling is a challenge in itself since it implies reaching out to | + | <p>Sampling the human skin microbiome involved reaching out to a large cohort of people in the European Union, given the constraints imposed for collecting human derived samples and shipping of sampling kits during the lockdown. Social distancing measures brought additional constraints that had to be dealt with to achieve our objectives. |
| − | a
| + | |
| − | large cohort and collecting human being derived samples. In the context of a
| + | .</p> |
| − | pandemic other constraints are added because of social distancing measures.</p>
| + | |
| | | | |
| | <img | | <img |
| Line 233: |
Line 240: |
| | <p><b class="heading">2. Engineer the Skin Microbiome</b></p> | | <p><b class="heading">2. Engineer the Skin Microbiome</b></p> |
| | <ul> | | <ul> |
| − | <li><i>Staphylococcus epidermidis</i> is not used in synthetic biology and no tools are | + | |
| − | currently available to engineer it</li>
| + | <li> |
| − | <li>Thw two main challenges in using <i>S. epidermidis</i> in
| + | The main difficulties we have encountered in processing <i>S. epidermidis</i> in synthetic biology are twofold:</li> |
| − | synthetic biology are:</li>
| + | |
| | </ul> | | </ul> |
| | <img | | <img |
| Line 258: |
Line 264: |
| | <div class="text"> | | <div class="text"> |
| | <p><b class="heading">1. Quaranskin</b></p> | | <p><b class="heading">1. Quaranskin</b></p> |
| − | <p>Quaranskin is a study involving the collection of skin microbiome samples during the | + | <p>While under lockdown, we sought to build a project that could involve citizens in science while maintaining social distancing. |
| − | COVID-19 pandemic and
| + | The following solutions were developed accordingly. |
| − | observing the impact of environmental factors on the skin microbiome.
| + | |
| | </p> | | </p> |
| | + | <br /> |
| | <ul> | | <ul> |
| − | <li>We took <b>ethical considerations</b> very seriously by submitting our project to | + | <li>Designing a skin microbiome cohort study involving participants from the European Union |
| − | the French national ethics committee in order to obtain their approval before
| + | |
| − | starting the study
| + | |
| | </li> | | </li> |
| − | <li>In order to include <b>citizen participation</b>, we designed a smapling kit | + | <li>Setting up a self-sampling kit delivered by post, for participants to anonymously provide samples of their skin microbiome along with a questionnaire detailing their habits |
| − | containing all the material required for sampling the skin microbiome and set up
| + | |
| − | mailing system to ship and collect back the samples from participants
| + | |
| | </li> | | </li> |
| − | <li>We are building an <b>Open Database</b> of skin microbiome during the COVID-19 | + | <li>Building an open database of the skin microbiome to foster open science |
| − | pandemic
| + | |
| | </li> | | </li> |
| | + | <li>Obtain approval from the Committee for People’s Protection and the assistance of legal experts to ensure project safety and compliance |
| | + | </li> |
| | + | |
| | </ul> | | </ul> |
| | <br /> | | <br /> |
| | <p><b class="heading">2. EpiFlex, EpiGlow, EpiGrow</b></p> | | <p><b class="heading">2. EpiFlex, EpiGlow, EpiGrow</b></p> |
| − | <p>These three projects aims to develop tools to make S. epidermidis a good chassis for | + | <p>These three projects aims to develop tools to make <i>S. epidermidis</i> a good chassis for |
| | Synthetic biology. | | Synthetic biology. |
| | </p> | | </p> |
| Line 308: |
Line 312: |
| | <div class="text"> | | <div class="text"> |
| | <p><b class="heading">What is the Skin Microbiome?</b></p> | | <p><b class="heading">What is the Skin Microbiome?</b></p> |
| − | <p>The human skin microbiome is a vast and very large ecosystem of microorganisms that | + | <p>The human skin microbiome is a rich ecosystem of microorganisms that occupy the human skin at the level of the hypodermis, dermis, and epidermis. |
| − | occupy the human skin at the level of the hypodermis, dermis, and epidermis. It is very
| + | |
| − | numerous and very diverse, a real petri dish hidden in plain sight.
| + | |
| | </p> | | </p> |
| | <br /> | | <br /> |
| − | <p><b class="heading">How the Skin Microbiome plays a role in the skin health?</b></p> | + | <p><b class="heading">What role does the skin microbiome play in skin health? </b></p> |
| − | <p>The human skin microbiome is very tightly linked to the health of its host in numerous | + | <p>The human skin microbiome is tightly linked to the health of its host. Microorganisms in the skin microbiome prevent colonization of the skin by pathogenic microorganisms, and help train the immune system to be better prepared to fight pathogens. The skin microbiome is also involved in various pathologies, like atopic dermatitis, where its overall diversity is reduced in favor of Staphylococcus aureus which is over represented. |
| − | ways. First of all the microorganisms of the skin microbiome prevent the colonization of
| + | |
| − | the skin by pathological microorganisms, and help to train the immune system to make it
| + | |
| − | more prepared to face pathogens. It also directly involved in various pathologies, like
| + | |
| − | atopic dermatitis, where its overall diversity is reduced and Staphylococcus aureus is
| + | |
| − | over represented.
| + | |
| | </p> | | </p> |
| | <br /> | | <br /> |
| − | <p><b class="heading">Why studying the composition of the Skin Microbiome?</b></p> | + | <p><b class="heading">Why study the Skin Microbiome composition?</b></p> |
| | <p> | | <p> |
| | <ul> | | <ul> |
| − | <li>Most of the previous studies which lead to understand the skin microbiome by | + | <li>Most of the previous studies which on the skin microbiome performed by sampling human volunteers, were based on North American subjects. From these results, current evidence suggests a greater microbial diversity to be a beneficial trait. However there is a need for greater diversity in the participant pools from which this data is derived. Thus, a study observing human skin microbiome among a European population would provide an interesting perspective on skin microbiome studies. |
| − | sampling human volunteers were based on North American subjects. Form these results,
| + | |
| − | current evidence suggests a greater microbial diversity to be a beneficial trait,
| + | |
| − | however there is a need for greater diversity in the participant pools from which
| + | |
| − | this data is derived. Thus, a study observing human skin microbiome among a European
| + | |
| − | population would give new data increasing our knowledge of the skin microbiome.
| + | |
| | </li> | | </li> |
| − | <li>Besides the current global environment wherein a significant number of people are | + | <li>In today's global environment a significant number of people minimize their interactions with others. This represents a good opportunity to observe the environmental impact on the skin microbiome in a context of simplified interactions. |
| − | minimizing their interactions with other people is a good opportunity to observe
| + | |
| − | environmental impact on skin microbiome in a more simplified model.
| + | |
| | </li> | | </li> |
| − | <li>Also, by taking samples from the skin microbiome during the COVID-19 pandemic, we | + | <li>By taking samples from the skin microbiome during the COVID-19 pandemic, we will have preserved evidence of the influence of the social restrictions induced by the pandemic on the skin microbiome. |
| − | will have preserved evidence of the influence of the social restrictions induced by
| + | |
| − | the pandemic on the skin microbiome.
| + | |
| | </li> | | </li> |
| | </ul> | | </ul> |
| Line 345: |
Line 333: |
| | <img | | <img |
| | src="https://static.igem.org/mediawiki/2020/8/80/T--Paris_Bettencourt--Poster_SkinMicrobiomeIllustration.png"> | | src="https://static.igem.org/mediawiki/2020/8/80/T--Paris_Bettencourt--Poster_SkinMicrobiomeIllustration.png"> |
| | + | |
| | + | <br/> |
| | + | |
| | + | <p>References</p> |
| | + | <ol class="references"> |
| | + | <li>“Your Body Is a Wonderland ... of Bacteria.” Science | AAAS, May 28, 2009. https://www.sciencemag.org/news/2009/05/your-body-wonderland-bacteria. |
| | + | </li> |
| | + | <li>Baviera, Giuseppe, Maria Chiara Leoni, Lucetta Capra, Francesca Cipriani, Giorgio Longo, Nunzia Maiello, Giampaolo Ricci, and Elena Galli. “Microbiota in Healthy Skin and in Atopic Eczema.” Review Article. BioMed Research International, July 13, 2014. https://doi.org/https://doi.org/10.1155/2014/436921. |
| | + | </li> |
| | + | <li>OpenStax. “5.1 Layers of the Skin.” In Anatomy and Physiology. OpenStax, 2013. https://opentextbc.ca/anatomyandphysiology/chapter/5-1-layers-of-the-skin/. |
| | + | </li> |
| | + | <li>Byrd, Allyson L., Yasmine Belkaid, and Julia A. Segre. “The Human Skin Microbiome.” Nature Reviews Microbiology 16, no. 3 (March 2018): 143–55. https://doi.org/10.1038/nrmicro.2017.157. |
| | + | </li> |
| | + | <li>Schommer, Nina N., and Richard L. Gallo. “Structure and Function of the Human Skin Microbiome.” Trends in Microbiology 21, no. 12 (December 2013): 660–68. https://doi.org/10.1016/j.tim.2013.10.001. |
| | + | </li> |
| | + | <li>Alexeyev, Oleg A. “Bacterial Landscape of Human Skin: Seeing the Forest for the Trees.” Experimental Dermatology 22, no. 7 (2013): 443–46. https://doi.org/10.1111/exd.12160. |
| | + | </li> |
| | + | </ol> |
| | </div> | | </div> |
| | </div> | | </div> |
| Line 364: |
Line 370: |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| | <div class="text"> | | <div class="text"> |
| − | <p>Quaranskin, a combination of quarantine and skin, is a project based on the collection | + | <p>Quaranskin, a word derived by the combination of Quarantine and Skin, is a project that brings together all the components to collect and analyze the skin microbiome samples collected from participants across Europe. Within this study, we aimed to investigate the impact of behavioral factors such as hygiene, exercise, and social interaction, on the composition of the human skin microbiome. |
| − | and analysis of skin microbiome samples, collected from participants across Europe.
| + | |
| − | </p>
| + | |
| − | <p>We aim to understand if there are correlations between behavioral characteristics that
| + | |
| − | involve activity, hygiene and human interaction, and the diversity and composition of
| + | |
| − | skin microbes at four body sites.
| + | |
| | </p> | | </p> |
| | + | |
| | <img | | <img |
| | src="https://static.igem.org/mediawiki/2020/6/6e/T--Paris_Bettencourt--Poster_QuaranskinStudy1.png"> | | src="https://static.igem.org/mediawiki/2020/6/6e/T--Paris_Bettencourt--Poster_QuaranskinStudy1.png"> |
| | + | <br /> |
| | <br /> | | <br /> |
| | <p><b class="heading">Study Pipeline</b></p> | | <p><b class="heading">Study Pipeline</b></p> |
| Line 378: |
Line 381: |
| | <img | | <img |
| | src="https://static.igem.org/mediawiki/2020/1/11/T--Paris_Bettencourt--Poster_QuaranskinStudy2.png"> | | src="https://static.igem.org/mediawiki/2020/1/11/T--Paris_Bettencourt--Poster_QuaranskinStudy2.png"> |
| − | <p><b>Participants recruitment</b></p> | + | <br /> |
| − | <p>Emails are sent to all the members of our institution, the CRI, and all the european | + | <p><b>Participants recruitment</b></p> |
| − | iGEMers, by focusing on people form countries where confinement or social distanciation
| + | <p>Emails are sent to European citizens and iGEMers, focusing on people whose countries where subject to social restrictions due to the pandemic. The expected number of participants is 70. |
| − | are set up. The total number of participants expected is 70.
| + | |
| | </p> | | </p> |
| | <p><b>Participants enrollment</b></p> | | <p><b>Participants enrollment</b></p> |
| − | <p>To be involved in the study each participants has to fill in a participation form and | + | <p>Each participant has to fill a participation form and sign a consent form to be part of the study. After signing up to participate in the study, they are asked to create an account on a platform called Open Humans. Open Humans is a community-based platform that enables personal data collections across data streams, giving individuals more personal data access and control of sharing authorizations, and enabling academic research as well as patient-led projects. |
| − | link to it a signed and dated consent form.
| + | |
| | </p> | | </p> |
| − | <p>A link is sent to them allowing them to create a account on the OpenHumans platform in | + | <p>Participants are sent a link allowing them to create an account on the Open Humans platform that will generate an eight digit unique ID for each of them. This unique ID helps preserve anonymity of the participants in the study. |
| − | order to furnish them an ID code which we use to keep anonymity
| + | |
| | </p> | | </p> |
| | <p><b>Participants action</b></p> | | <p><b>Participants action</b></p> |
| − | <p>Once they are officially enroll in the study, we send to the participants by mail a kit | + | <p>Once officially enrolled in the study, each participant is shipped a kit containing all the tools needed to sample their skin microbiome from 4 body sites. In parallel, the participants are asked to answer an online questionnaire with questions covering 4 main topics: personal characteristic (age, sex, nationality, etc.), hygiene habits, level of confinement and potential skin disorders. |
| − | containing all tools needed to sample microbiome from 4 body sites and to send them back
| + | |
| − | to us, and by email a link to answer an online questionnaire asking questions covering 4
| + | |
| − | main topics : The intrinsic characteristic (age, sexe, nationality...), the hygiene
| + | |
| − | habits, the level of confinement and the skin disorder appeared since February 2020.
| + | |
| | </p> | | </p> |
| | <p><b>Microbiome sequencing</b></p> | | <p><b>Microbiome sequencing</b></p> |
| − | <p>Once we receive the microbiome samples we send them directly to an external company, | + | <p>Samples are then sent to a sequencing company (Genewiz). Bacterial DNA extraction is performed from the samples, before amplification of the V3-V4 regions of the 16S RNA gene, and sequencing of the amplicons. |
| − | Genewiz. They’ll extract bacterial DNA from the samples, amplify the V3-V4 regions of
| + | |
| − | the 16S RNA gene, and then sequence the amplicons.
| + | |
| | </p> | | </p> |
| | <p><b>Statistical analysis</b></p> | | <p><b>Statistical analysis</b></p> |
| − | <p>After having analyzed the composition and diversity of each microbiome we’ll link these | + | <p>The results from composition and diversity analyses will be correlated to the questionnaires, to unveil any trend between the microbiome composition and characteristics of the lifestyle or skin disorders. |
| − | results to the answer to the questionnaire to finally find some correlations between
| + | |
| − | some microbiome compositions and some characteristics of the lifestyle or some skin
| + | |
| − | disorder
| + | |
| | </p> | | </p> |
| | <br /> | | <br /> |
| | | | |
| | <p><b class="heading">Data Analysis</b></p> | | <p><b class="heading">Data Analysis</b></p> |
| − | <p><b>1. Diversity analysis by index of hygiene, personal information, level of restriction | + | <p><b>1. Correlations between microbiome diversity and indexes of hygiene, personal information, and level of social restriction |
| | </b></p> | | </b></p> |
| − | <p>The microbiomes in the generated database are grouped by index value in each of the 3 | + | <p>The microbiomes in the generated database are grouped by index values in each of these 3 categories. By setting two indices, we can study the impact of the third element on the diversity of the microbiome. |
| − | categories. By setting two indices, we can study the impact of the third element on the
| + | |
| − | diversity of the microbiome
| + | |
| | </p> | | </p> |
| − | <p><b>2. Environmental factors which influence proportion of Staphylococcus | + | <p><b>2. Identify environmental factors influencing the proportions of Staphylococci |
| | </b></p> | | </b></p> |
| − | <p>We define a proportion threshold, then we identify all the people who present a | + | <p>A proportion threshold is defined and all individuals with a staphylococcal population above this threshold are isolated. Finally, we look for parameters common to these individuals. |
| − | population of Staphylococcus beyond this threshold. We finally look for parameters
| + | |
| − | common to these individuals,
| + | |
| | </p> | | </p> |
| − | <p><b>3. Researching existing microbiome composition among our data set | + | <p><b>3. Investigate eczematic people’s microbiome |
| | </b></p> | | </b></p> |
| − | <p>We want to compare a typical composition of eczematic microbiome found in literature, | + | <p>We want to compare a typical composition of eczematic microbiome, found in the literature, to data collected from our subjects. |
| − | with our data
| + | |
| | </p> | | </p> |
| − | <p><b>4. Analysis of data based on common symptoms | + | <p><b>4. Analyse data based on common symptoms |
| | </b></p> | | </b></p> |
| − | <p>When a significant number of people present the same symptom, independently of the | + | <p>When a significant number of people present the same symptom, independently of the environment and lifestyle, we want to make a synthesis of the microbiome composition related to this symptom. |
| − | environment and lifestyle, we want to make a synthesis of the typical composition of the
| + | |
| − | microbiome for this symptom.
| + | |
| | </p> | | </p> |
| | </div> | | </div> |
| Line 450: |
Line 434: |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| | <div class="text"> | | <div class="text"> |
| − | <p><b class="heading">Ethical consideration</b></p> | + | <p><b class="heading">Ethical considerations</b></p> |
| − | <p>As Quaranskin is a collection of data extracted from human derived samples (skin | + | <p>As Quaranskin is a collection of data extracted from human derived samples and contains personal information, our research depends on the legal procedures related to research involving human being. This leads to particular care to respect people’s privacy and data protection. |
| − | microbiome) and personal information (answer to the questionnaire), it’s important to
| + | |
| − | learn about the ethical rules that govern research involving human being in Europe in
| + | |
| − | order to respect the protection of the participants in our study.
| + | |
| | </p> | | </p> |
| − | <p>In France, Research Involving Human Being (RIPH) has to be approved and framed by the | + | <p>In France, Research Involving Human Being (RIPH) has to be approved and framed by the Committees for the Protection of Persons (CPP). |
| − | Committees for the Protection of Persons (CPP).
| + | |
| | </p> | | </p> |
| − | <p>We have submitted to the ethics committee a complete file presenting our study in detail. | + | <p>We have submitted to the ethics committee a complete file presenting our study in detail. This file consisted mainly of a research protocol plus an information leaflet for the participants. Even though we already recruited participants and set up all the logistic aspects of the study, we are still waiting for their feedback to collect and analyse the samples. |
| − | This file consisted mainly of a research protocol and all the information documents for
| + | |
| − | the study participants. Even though we already recruit participant and set up all the
| + | |
| − | logistic aspect of the study, we are still waiting for their approval to collect and
| + | |
| − | analyse samples.
| + | |
| | </p> | | </p> |
| | | | |
| | <p><b class="heading">Contribution to the scientific community</b></p> | | <p><b class="heading">Contribution to the scientific community</b></p> |
| | <ol> | | <ol> |
| − | <li>Increase the knowledge we have about the microbiome and more precisely about the | + | <li>Increase knowledge on the skin microbiome, more specifically the environmental factors that influence it |
| − | external factors that can impact it.
| + | |
| | </li> | | </li> |
| − | <li>Create an open database of skin microbiome from people in the context of a pandemic. | + | <li>Create a skin microbiome open database in the special context of a pandemic with living restrictions |
| | </li> | | </li> |
| − | <li>Develop Science@Home by providing pipeline and protocols useful for future | + | <li>Develop Science@Home by providing reproducible pipeline and protocols which can be used in future studies |
| − | microbiome studies based on citizen science
| + | |
| | </li> | | </li> |
| − | <li>Instruct participants about their microbiome by sending them back their microbiome | + | <li>Instruct participants about their skin microbiome by sending them back their skin microbiome profile after analysis |
| − | profile after analysis.
| + | |
| | </li> | | </li> |
| | </ol> | | </ol> |
| Line 499: |
Line 472: |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| | <div class="text"> | | <div class="text"> |
| − | <p>Biological engineering allowed us to develop solutions for our objectives.</p>
| + | |
| | <p><b class="heading">Purpose</b></p> | | <p><b class="heading">Purpose</b></p> |
| | <p>We aim to sense and modulate population dynamics of the skin microbiome in order to help | | <p>We aim to sense and modulate population dynamics of the skin microbiome in order to help |
| Line 509: |
Line 482: |
| | </p> | | </p> |
| | <p><b class="heading"><i>S. epidermidis</i></b></p> | | <p><b class="heading"><i>S. epidermidis</i></b></p> |
| − | <p><i>S. epidermidis</i> represents approximately 90% of the aerobic skin flora, and about 5% of | + | <p><i>S. epidermidis</i> represents approximately 90% of the aerobic skin flora, and about |
| | + | 5% of |
| | the overall skin microbiome species. It is a non-motile gram-positive coccus, and a | | the overall skin microbiome species. It is a non-motile gram-positive coccus, and a |
| | facultative anaerobe. Its mainly mutualistic behavior makes it a very good candidate to | | facultative anaerobe. Its mainly mutualistic behavior makes it a very good candidate to |
| Line 543: |
Line 517: |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| | <div class="text"> | | <div class="text"> |
| − | <div class="subsection half"> | + | <p>The bacterium <i>Staphylococcus epidermidis</i> has only few tools available for efficient |
| − | <p>The bacterium Staphylococcus epidermidis has only few tools available for efficient expression of recombinant DNA and genetic engineering. This generated the idea to develop a MoClo toolkit for S.epidermidis, the EpiFlex toolkit. | + | expression of recombinant DNA and genetic engineering. This generated the idea to |
| − | </p>
| + | develop a MoClo toolkit for S.epidermidis, the EpiFlex toolkit. |
| − | <p>EpiFlex aims to make the bacterium a chassis for synthetic biology.
| + | </p> |
| − | </p>
| + | |
| − | </div>
| + | |
| | | | |
| − | <div class="subsection half logo-align"> | + | <div class="subsection full logo-align"> |
| − | <img src="https://static.igem.org/mediawiki/2020/9/9b/T--Paris_Bettencourt--Poster_EpiGlow72.jpg" class="logo"> | + | <img src="https://static.igem.org/mediawiki/2020/b/b0/T--Paris_Bettencourt--Poster_EpiFlexLogo.png" |
| | + | class="logo"> |
| | </div> | | </div> |
| − | | + | <p>EpiFlex aims to make the <i>Staphylococcus epidermidis</i> bacterium a chassis for synthetic biology. |
| − | <div class="clear"></div>
| + | </p> |
| − | <br /> | + | |
| | | | |
| | <p><b class="heading">MoClo Toolkit</b></p> | | <p><b class="heading">MoClo Toolkit</b></p> |
| − | <p>The MoClo is a modular cloning method based on Golden Gate assembly. EpiFlex is a Moclo toolkit developed with parts that function specifically in S.epidermidis. | + | <p>MoClo is a modular cloning method based on Golden Gate assembly. EpiFlex is a Moclo |
| | + | toolkit developed with parts that function specifically in S.epidermidis. |
| | </p> | | </p> |
| | <p><b class="heading">The MoClo Concept</b></p> | | <p><b class="heading">The MoClo Concept</b></p> |
| − | <img src="https://static.igem.org/mediawiki/2020/6/6b/T--Paris_Bettencourt--Poster_MoCloConcept.png"> | + | <img |
| | + | src="https://static.igem.org/mediawiki/2020/6/6b/T--Paris_Bettencourt--Poster_MoCloConcept.png"> |
| | + | |
| | + | <p><b class="heading">Plasmid and Parts Design</b></p> |
| | + | <img |
| | + | src="https://static.igem.org/mediawiki/2020/9/9c/T--Paris_Bettencourt--Poster_PlasmidParts.png"> |
| | + | <p>We chose a fluorescent reporter as a cloning selection marker to avoid the extra cost of |
| | + | reagents needed in traditional screening methods such as blue-white screening which |
| | + | requires X-gal. |
| | + | </p> |
| | + | <p>An important feature of our p1 and p2 backbones is the fact that they're <i>E. coli</i> |
| | + | -> <i>S. |
| | + | epidermidis</i> shuttle vectors. This is important for a two step cloning workflow |
| | + | as <i>E. |
| | + | coli</i> is an easy host for cloning and plasmid amplification before seeing the |
| | + | performance |
| | + | of the cassette in <i>S. epidermidis</i>. |
| | + | </p> |
| | </div> | | </div> |
| | </div> | | </div> |
| Line 574: |
Line 564: |
| | <div class="info"> | | <div class="info"> |
| | <!--Write the title of the section --> | | <!--Write the title of the section --> |
| − | <div class="title"> Section 2 </div> | + | <div class="title">EpiGlow</div> |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| − | <div class="text"> Use this section to explain whatever you would like! Suggestions: Safety, | + | <div class="text"> |
| − | Human Practices, Measurement, etc. </div> | + | <p>EpiGlow is the proof of concept of our EpiFlex toolkit. We chose to express mCherry |
| | + | in <i>S. epidermidis</i> to demonstrate that our parts are functional. |
| | + | </p> |
| | + | |
| | + | <div class="subsection full logo-align"> |
| | + | <img src="https://static.igem.org/mediawiki/2020/b/b6/T--Paris_Bettencourt--Poster_EpiGlowLogo.png" |
| | + | class="logo"> |
| | + | </div> |
| | + | |
| | + | <p>The expression of mCherry, a fluorescent protein, allows the easy characterization of |
| | + | different regulatory sequences, such as promoter, RBS and terminator. |
| | + | </p> |
| | + | |
| | + | <p><b class="heading">Cloning Pipeline</b></p> |
| | + | <ul> |
| | + | <li>To evade the type IV restriction barriers in <i>S. epidermidis</i>, we used a |
| | + | dam-/dcm- strain of <i>E. coli</i>.</li> |
| | + | <li>We had to clone into an efficient cloning strain before growing our plasmid in the |
| | + | dam-/dcm- <i>E. coli</i> since the latter is not very efficient for cloning.</li> |
| | + | </ul> |
| | + | <img |
| | + | src="https://static.igem.org/mediawiki/2020/6/60/T--Paris_Bettencourt--Poster_EpiGlowProtocol.png"> |
| | + | |
| | + | <p><b class="heading">Protocols</b></p> |
| | + | <ul> |
| | + | <li>We built a TU coding for mCherry. We used the following parts of the EpiFlex toolkit |
| | + | : |
| | + | </li> |
| | + | </ul> |
| | + | |
| | + | <img |
| | + | src="https://static.igem.org/mediawiki/2020/b/bd/T--Paris_Bettencourt--Poster_EpiGlowProtocol2.png"> |
| | + | |
| | + | <ul> |
| | + | <li>We explored and optimized electroporation protocols<sup>1</sup> by testing different voltages and a |
| | + | newer heat shock/ electroporation combination<sup>2</sup>, to see which protocol would yield |
| | + | more transformants. |
| | + | </li> |
| | + | </ul> |
| | + | |
| | + | <p><b class="heading">Results</b></p> |
| | + | <ul> |
| | + | <li>Using our EpiFlex system, we were able to successfully build a construct that |
| | + | expressed mCherry in <i>S. epidermidis</i> |
| | + | </li> |
| | + | </ul> |
| | + | |
| | + | <img |
| | + | src="https://static.igem.org/mediawiki/2020/1/14/T--Paris_Bettencourt--Poster_EpiGolwResult1.png"> |
| | + | |
| | + | <ul> |
| | + | <li>In our optimization of the electroporation of <i>S. epidermidis</i>, we found that a |
| | + | voltage of 2.5kV yielded the greatest transformation efficiency. We achieve around 3 |
| | + | - 7 transformants per plate using this protocol. |
| | + | </li> |
| | + | </ul> |
| | + | |
| | + | <img |
| | + | src="https://static.igem.org/mediawiki/2020/3/3b/T--Paris_Bettencourt--Poster_EpiGolwResult2.png"> |
| | + | |
| | + | <br/> |
| | + | |
| | + | <p>References</p> |
| | + | <ol class="references"> |
| | + | <li>Lee, Jean YH, et al. "Mining the Methylome Reveals Extensive Diversity in |
| | + | Staphylococcus epidermidis Restriction Modification."Mbio10.6 (2019). |
| | + | </li> |
| | + | <li>Chen, Y. Erin, et al. "Decoding commensal-host communication through genetic |
| | + | engineering of <i>Staphylococcus epidermidis</i>."bioRxiv(2019): 664656. |
| | + | </li> |
| | + | </ol> |
| | + | </div> |
| | </div> | | </div> |
| | </div> | | </div> |
| Line 589: |
Line 650: |
| | <div class="info"> | | <div class="info"> |
| | <!--Write the title of the section --> | | <!--Write the title of the section --> |
| − | <div class="title"> Section 3 </div> | + | <div class="title">EpiGrow</div> |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| − | <div class="text"> Use this section to explain whatever you would like! Suggestions: Safety, | + | <div class="text"> |
| − | Human Practices, Measurement, etc. </div> | + | <p>To effectively implement our goal of developing <i>Staphylococcus epidermidis</i> as a |
| | + | chassis |
| | + | for synthetic biology of the skin microbiome, it was essential to explore the growth of |
| | + | our target organism. |
| | + | </p> |
| | + | |
| | + | <img |
| | + | src="https://static.igem.org/mediawiki/2020/3/3e/T--Paris_Bettencourt--Poster_EpiGrowLogo.png"> |
| | + | |
| | + | <p>We used the <i>S. epidermidis</i> strain ATCC12228 |
| | + | </p> |
| | + | |
| | + | <p><b class="heading">Parameters Tested</b></p> |
| | + | <p><b>1. Temperature</b></p> |
| | + | <p>We chose to test the temperature range from 32°C-42°C. In fact, skin may reach |
| | + | temperatures as low as 33°C (hands, feet, nose), up to 40°C (severe conditions). |
| | + | </p> |
| | + | <p>At each temperature, the growth was measured in TSB for 15 hours via optical density measurements. |
| | + | </p> |
| | + | <p><b>2. Acidity</b></p> |
| | + | <p>The acid mantle of the skin is key as it neutralizes alkaline-based aggressors (such as |
| | + | harsh surfactants) and maintains the optimal acid environment in which skin’s natural |
| | + | flora can thrive. The skin’s pH generally fluctuates between 5.6 and 6.4 (armpit, |
| | + | genital area) depending on the region of the body it is covering. |
| | + | </p> |
| | + | <p>We tested in pH range from pH3 to pH10. The measurement has been done in the same way as for |
| | + | the Temperature tests. |
| | + | </p> |
| | + | <p><b>3. Salinity</b></p> |
| | + | <p>With respect to the skin, there can be variations in salinity caused mainly by sweat and |
| | + | sebaceous glands. The evaporation of water from the release of heat enables the salts to |
| | + | remain on the skin. |
| | + | </p> |
| | + | <p>We varied the salinity of the media from 0.5% to 5.5% of NaCl. Again, the measurements |
| | + | have been done over 15 hours of growth in TSB. |
| | + | </p> |
| | + | |
| | + | <p><b class="heading">Results</b></p> |
| | + | <ol> |
| | + | <li>The growth of <i>S. epidermidis</i> is stunted at lower temperatures, and it grows best at |
| | + | 37°C which is the normal human body temperature. |
| | + | </li> |
| | + | <li><i>S. epidermidis</i> thrives better in the neutral and basic pH conditions. |
| | + | </li> |
| | + | <li><i>S. epidermidis</i> is halo tolerant and it grows best in media with about 0.5 |
| | + | percent of NaCl. |
| | + | </li> |
| | + | </ol> |
| | + | <br/> |
| | + | |
| | + | <img |
| | + | src="https://static.igem.org/mediawiki/2020/b/b6/T--Paris_Bettencourt--Poster_EpiGrowGrowthRates.png"> |
| | + | <br/> |
| | + | |
| | + | <p>References</p> |
| | + | <ol class="references"> |
| | + | <li>Bierman, William (1936-04-04). "The Temperature of the Skin Surface". Journal of the |
| | + | American Medical Association. 106 (14): 1158. doi:10.1001/jama.1936.02770140020007. |
| | + | ISSN 0002-9955 |
| | + | </li> |
| | + | <li>Kanitakis, Jean (2002-07-02). "Anatomy, histology and immunohistochemistry of normal |
| | + | human skin". European Journal of Dermatology. 12 (4): 390–9, quiz 400–1. ISSN |
| | + | 1167-1122. PMID 12095893 |
| | + | </li> |
| | + | <li>Benedict, FG; Miles, WR; Johnson, A (June 1919). "The Temperature of the Human |
| | + | Skin". Proceedings of the National Academy of Sciences of the United States of |
| | + | America. 5 (6): 218–22. Bibcode:1919PNAS....5..218B. doi:10.1073/pnas.5.6.218. PMC |
| | + | 1091574. PMID 16576376 |
| | + | </li> |
| | + | <li>Edmonds-Wilson S,Nurinova N, Zapka C et al. “Review of human hand microbiome |
| | + | research”.Journal of Dermatological Science (2015), 3-12,80(1). |
| | + | doi.org/10.1016/j.jdermsci.2015.07.006 |
| | + | </li> |
| | + | <li>Marples, M. J. The Ecology of the Human Skin. Charles C Thomas Publisher. |
| | + | Springfield, Ill. (1965) pgs103-154 |
| | + | </li> |
| | + | <li>Aly, Raza. Clinical Skin Microbiology. Springfield, IL: Thomas Books, 1987. 11-35. |
| | + | </li> |
| | + | <li>Elias, Peter M., and Kenneth R. Feingold, eds. Skin Barrier. Danbury: Marcel Dekker |
| | + | Incorporated, 2006 |
| | + | </li> |
| | + | </ol> |
| | + | </div> |
| | </div> | | </div> |
| | </div> | | </div> |
| Line 611: |
Line 754: |
| | <div class="info"> | | <div class="info"> |
| | <!--Write the title of the section --> | | <!--Write the title of the section --> |
| − | <div class="title"> Results</div> | + | <div class="title"> Future Work - EpiFlex and EpiGlow</div> |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| − | <div class="text"> What did your team achieve? What do you plan to work on moving forward? | + | <div class="text"> |
| | + | <p><b class="heading">In the short run |
| | + | </b></p> |
| | + | <ul> |
| | + | <li>Improve transformation efficiency from electroporation |
| | + | </li> |
| | + | <li>Build more constructs using the EpiFlex toolkit to characterize all the parts |
| | + | </li> |
| | + | </ul> |
| | + | <p><b class="heading">In the long run |
| | + | </b></p> |
| | + | <ul> |
| | + | <li>Using EpiFlex to build a genetic circuit aiming to control population dynamics in the |
| | + | skin microbiome. |
| | + | </li> |
| | + | </ul> |
| | </div> | | </div> |
| | </div> | | </div> |
| Line 627: |
Line 785: |
| | <div class="info"> | | <div class="info"> |
| | <!--Write the title of the section --> | | <!--Write the title of the section --> |
| − | <div class="title">References and Acknowledgements</div> | + | <div class="title">Future Work - EpiGrow</div> |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| − | <div class="text">If not already cited in other sections of your poster, what literature sources | + | <div class="text"> |
| − | did you reference on this poster? Who helped or advised you? </div>
| + | <p><b class="heading">EpiGrow</b></p> |
| | + | <ul> |
| | + | <li>We would like to investigate the difference of growth kinetics between <i>S. epidermidis</i> |
| | + | grown in 2D and in 3D media. |
| | + | </li> |
| | + | <li>We decided to build an artificial skin model of the human palm to develop a method to |
| | + | measure growth on 2D media while having comparable data with growth in 3D media. |
| | + | </li> |
| | + | </ul> |
| | + | </div> |
| | </div> | | </div> |
| | </div> | | </div> |
| Line 693: |
Line 860: |
| | <!--Write the text explaining this section --> | | <!--Write the text explaining this section --> |
| | <div class="text"> | | <div class="text"> |
| − | <p><b class="heading">Acknowledgements</b></p> | + | <p>We would like to thank the following people for their support during the course of this |
| − | | + | project</p> |
| − | | + | <b> |
| − | | + | |
| − | | + | |
| − | <p>Stéphanie Leclerc-Mercier</p> | + | |
| − | | + | |
| − | | + | <p>Stéphanie Leclerc-Mercier</p> |
| − | | + | |
| − | | + | |
| − | | + | |
| − | | + | |
| − | <p>Jean-Christophe Thalabard</p> | + | |
| − | <p>Bastian Greshake Tzovaras</p> | + | |
| − | <br/> | + | <p>Jean-Christophe Thalabard</p> |
| − | | + | <p>Bastian Greshake Tzovaras</p> |
| | + | </b> |
| | + | <br /> |
| | + | |
| | <p><b class="heading">Sponsors</b></p> | | <p><b class="heading">Sponsors</b></p> |
| | <div class="subsection third logo-align"> | | <div class="subsection third logo-align"> |
| − | <img | + | <img src="https://static.igem.org/mediawiki/2020/9/95/T--Paris_Bettencourt--Poster_CRI.png" |
| − | src="https://static.igem.org/mediawiki/2020/9/95/T--Paris_Bettencourt--Poster_CRI.png" class="logo">
| + | class="logo"> |
| | </div> | | </div> |
| | <div class="subsection third logo-align"> | | <div class="subsection third logo-align"> |
| − | <img | + | <img src="https://static.igem.org/mediawiki/2020/a/a3/T--Paris_Bettencourt--Poster_FondationBettencourtSchueller.png" |
| − | src="https://static.igem.org/mediawiki/2020/a/a3/T--Paris_Bettencourt--Poster_FondationBettencourtSchueller.png" class="logo">
| + | class="logo"> |
| | </div> | | </div> |
| | <div class="subsection third logo-align"> | | <div class="subsection third logo-align"> |
| − | <img | + | <img src="https://static.igem.org/mediawiki/2020/c/c7/T--Paris_Bettencourt--Poster_Inserm.png" |
| − | src="https://static.igem.org/mediawiki/2020/4/47/T--Paris_Bettencourt--Poster_Geneious.png" class="logo">
| + | class="logo"> |
| | </div> | | </div> |
| | + | |
| | <div class="clear"></div> | | <div class="clear"></div> |
| | <br /> | | <br /> |
| | | | |
| | <div class="subsection third logo-align"> | | <div class="subsection third logo-align"> |
| − | <img | + | <img src="https://static.igem.org/mediawiki/2020/8/85/T--Paris_Bettencourt--Poster_UP.jpg" |
| − | src="https://static.igem.org/mediawiki/2020/e/e1/T--Paris_Bettencourt--Poster_Genewiz.png" class="logo">
| + | class="logo"> |
| | </div> | | </div> |
| | <div class="subsection third logo-align"> | | <div class="subsection third logo-align"> |
| − | <img | + | <img src="https://static.igem.org/mediawiki/2020/4/47/T--Paris_Bettencourt--Poster_Geneious.png" |
| − | src="https://static.igem.org/mediawiki/2020/d/de/T--Paris_Bettencourt--Poster_IDT.png" class="logo">
| + | class="logo"> |
| | </div> | | </div> |
| | <div class="subsection third logo-align"> | | <div class="subsection third logo-align"> |
| − | <img | + | <img src="https://static.igem.org/mediawiki/2020/e/e1/T--Paris_Bettencourt--Poster_Genewiz.png" |
| − | src="https://static.igem.org/mediawiki/2020/f/fc/T--Paris_Bettencourt--Poster_iGEM.png" class="logo">
| + | class="logo"> |
| | </div> | | </div> |
| | + | |
| | <div class="clear"></div> | | <div class="clear"></div> |
| | <br /> | | <br /> |
| | | | |
| | <div class="subsection third logo-align"> | | <div class="subsection third logo-align"> |
| − | <img | + | <img src="https://static.igem.org/mediawiki/2020/d/de/T--Paris_Bettencourt--Poster_IDT.png" |
| − | src="https://static.igem.org/mediawiki/2020/6/65/T--Paris_Bettencourt--Poster_OpenHumans.png" class="logo">
| + | class="logo"> |
| | </div> | | </div> |
| | <div class="subsection third logo-align"> | | <div class="subsection third logo-align"> |
| − | <img | + | <img src="https://static.igem.org/mediawiki/2020/f/fc/T--Paris_Bettencourt--Poster_iGEM.png" |
| − | src="https://static.igem.org/mediawiki/2020/f/f6/T--Paris_Bettencourt--Poster_Snapgene.png" class="logo">
| + | class="logo"> |
| | </div> | | </div> |
| | <div class="subsection third logo-align"> | | <div class="subsection third logo-align"> |
| − | <img | + | <img src="https://static.igem.org/mediawiki/2020/6/65/T--Paris_Bettencourt--Poster_OpenHumans.png" |
| − | src="https://static.igem.org/mediawiki/2020/8/8a/T--Paris_Bettencourt--Poster_TwistBioscience.png" class="logo">
| + | class="logo"> |
| | </div> | | </div> |
| | + | |
| | <div class="clear"></div> | | <div class="clear"></div> |
| | <br /> | | <br /> |
| | + | |
| | + | <div class="subsection third logo-align"> |
| | + | <img src="https://static.igem.org/mediawiki/2020/f/f6/T--Paris_Bettencourt--Poster_Snapgene.png" |
| | + | class="logo"> |
| | + | </div> |
| | + | <div class="subsection third logo-align"> |
| | + | <img src="https://static.igem.org/mediawiki/2020/8/8a/T--Paris_Bettencourt--Poster_TwistBioscience.png" |
| | + | class="logo"> |
| | + | </div> |
| | </div> | | </div> |
| | </div> | | </div> |
